日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Real-World Effectiveness of Insulin Glargine 300 U/ml in People with Type 2 Diabetes Previously Treated with Tirzepatide: The DELIVER-T Study

胰岛素格列净 300 U/ml 在既往接受过替拉帕肽治疗的 2 型糖尿病患者中的真实世界疗效：DELIVER-T 研究

期刊:Diabetes Therapy
影响因子:2.6
doi:10.1007/s13300-025-01798-5
Ritzel, Robert; Davies, Melanie J; Hao, Lichen; Ji, Linong; Mk, Lintu; Mabunay, Aileen; Mauricio, Didac; Bailey, Timothy
代谢
糖尿病
免疫/内分泌
发表日期：2026
文献求助 收藏

Clinically meaningful improvements in treatment satisfaction in insulin-naïve people with type 2 diabetes post initiation of insulin glargine 300 U/mL: A post hoc analysis of real-world ATOS study

在开始使用甘精胰岛素 300 U/mL 后，2 型糖尿病初治患者的治疗满意度得到具有临床意义的改善：一项基于真实世界 ATOS 研究的事后分析

期刊:Diabetes Obesity & Metabolism
影响因子:5.7
doi:10.1111/dom.16415
Snoek, Frank; Galstyan, Gagik; Khan, Niaz; Tirosh, Amir; Kesavadev, Jothydev; Vargas-Uricoechea, Hernando; Baghous, Houssem; Mabunay, Maria Aileen; Grulovic, Natasa; Corp Dit Genti, Valerie; Msihid, Jerome; Harris, Stewart
代谢
糖尿病
免疫/内分泌
发表日期：2025
文献求助 收藏

Effectiveness and Safety of Insulin Glargine 300 U/ml in High-Risk Subgroups (Renal Impairment and Older Age ≥ 70 years) of Insulin-Naïve People with Type 2 Diabetes: A Post hoc Analysis of Real-World ATOS Study

在既往未接受过胰岛素治疗的2型糖尿病高危亚组（肾功能不全和年龄≥70岁）中，甘精胰岛素300 U/ml的有效性和安全性：一项基于真实世界ATOS研究的事后分析

期刊:Diabetes Therapy
影响因子:2.6
doi:10.1007/s13300-025-01785-w
Tirosh, Amir; Khan, Niaz; Vargas-Uricoechea, Hernando; Galstyan, Gagik; Al Shaikh, Abdul Rahman; Makkar, Brij Mohan; Mabunay, Maria Aileen; Melas-Melt, Lydie; Pilorget, Valerie; Karalliedde, Janaka
代谢
糖尿病
免疫/内分泌
发表日期：2025
文献求助 收藏

Real-World Effectiveness and Safety of Insulin Glargine 300 U/mL in Insulin-Naïve People with Type 2 Diabetes: the ATOS Study

ATOS 研究：胰岛素格列净 300 U/mL 在初次使用胰岛素的 2 型糖尿病患者中的真实世界疗效和安全性

期刊:Diabetes Therapy
影响因子:2.6
doi:10.1007/s13300-022-01266-4
Galstyan, Gagik R; Tirosh, Amir; Vargas-Uricoechea, Hernando; Mabunay, Maria Aileen; Coudert, Mathieu; Naqvi, Mubarak; Pilorget, Valerie; Khan, Niaz
代谢
糖尿病
免疫/内分泌
发表日期：2022
文献求助 收藏

Efficacy and Safety of Insulin Glargine 300 U/mL in People with Type 2 Diabetes Uncontrolled on Basal Insulin: The 26-Week Interventional, Single-Arm ARTEMIS-DM Study

胰岛素甘精300 U/mL治疗基础胰岛素治疗血糖控制不佳的2型糖尿病患者的疗效和安全性：一项为期26周的单臂干预性ARTEMIS-DM研究

期刊:Diabetes Therapy
影响因子:2.6
doi:10.1007/s13300-022-01271-7
Sethi, Bipin; Al-Rubeaan, Khalid; Unubol, Mustafa; Mabunay, Maria A; Berthou, Baptiste; Pilorget, Valerie; Vethakkan, Shireene R; Frechtel, Gustavo
代谢
糖尿病
MIS
免疫/内分泌
发表日期：2022
文献求助 收藏

Challenges and unmet needs in basal insulin therapy: lessons from the Asian experience

基础胰岛素治疗面临的挑战和未满足的需求：来自亚洲的经验教训

期刊:Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
影响因子:3
doi:10.2147/DMSO.S143046
Chan, Wing Bun; Chen, Jung Fu; Goh, Su-Yen; Vu, Thi Thanh Huyen; Isip-Tan, Iris Thiele; Mudjanarko, Sony Wibisono; Bajpai, Shailendra; Mabunay, Maria Aileen; Bunnag, Pongamorn
免疫/内分泌
发表日期：2017
文献求助 收藏

Optimizing Glycemic Control Through Titration of Insulin Glargine 100 U/mL: A Review of Current and Future Approaches with a Focus on Asian Populations

通过调整甘精胰岛素100 U/mL剂量优化血糖控制：以亚洲人群为重点的当前和未来方法综述

期刊:Diabetes Therapy
影响因子:2.6
doi:10.1007/s13300-017-0322-z
Deerochanawong, Chaicharn; Bajpai, Shailendra; Dwipayana, I Made Pande; Hussein, Zanariah; Mabunay, Maria Aileen; Rosales, Reynaldo; Tsai, Shih-Tzer; Tsang, Man Wo
免疫/内分泌
发表日期：2017
文献求助 收藏